Clinical role of breast MRI now and going forward

D Leithner, GJ Wengert, TH Helbich, S Thakur… - Clinical radiology, 2018 - Elsevier
Magnetic resonance imaging (MRI) is a well-established method in breast imaging, with
manifold clinical applications, including the non-invasive differentiation between benign and …

Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative …

CS Giess, ED Yeh, S Raza, RL Birdwell - Radiographics, 2014 - pubs.rsna.org
At magnetic resonance (MR) imaging, both normal and abnormal breast tissue enhances
after contrast material administration. The morphology and temporal degree of enhancement …

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort …

D Portalez, P Mozer, F Cornud, R Renard-Penna… - European urology, 2012 - Elsevier
BACKGROUND: Wide variations in acquisition protocols and the lack of robust diagnostic
criteria make magnetic resonance imaging (MRI) detection of prostate cancer (PCa) one of …

[HTML][HTML] Quantifying heterogeneity in human tumours using MRI and PET

MC Asselin, JPB O'Connor, R Boellaard… - European journal of …, 2012 - Elsevier
Most tumours, even those of the same histological type and grade, demonstrate
considerable biological heterogeneity. Variations in genomic subtype, growth factor …

Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?

F Galati, V Rizzo, G Moffa, C Caramanico… - European Radiology …, 2022 - Springer
Background Breast cancer (BC) includes different pathological and molecular subtypes. This
study aimed to investigate whether multiparametric magnetic resonance imaging (mpMRI) …

Quantifying tumor vascular heterogeneity with dynamic contrast‐enhanced magnetic resonance imaging: a review

X Yang, MV Knopp - BioMed Research International, 2011 - Wiley Online Library
Tumor microvasculature possesses a high degree of heterogeneity in its structure and
function. These features have been demonstrated to be important for disease diagnosis …

Breast cancer intratumour heterogeneity: current status and clinical implications

C Joseph, A Papadaki, M Althobiti, M Alsaleem… - …, 2018 - Wiley Online Library
Breast cancer (BC) is a heterogeneous disease that varies in presentation, morphological
features, behaviour, and response to therapy. High‐throughput molecular profiling studies …

[HTML][HTML] Breast cancer classification through multivariate radiomic time series analysis in DCE-MRI sequences

F Prinzi, A Orlando, S Gaglio, S Vitabile - Expert Systems with Applications, 2024 - Elsevier
Breast cancer is the most prevalent disease that poses a significant threat to women's
health. Despite the Dynamic Contrast-Enhanced MRI (DCE-MRI) has been widely used for …

Differences in molecular subtype reference standards impact AI-based breast cancer classification with dynamic contrast-enhanced MRI

Y Ji, HM Whitney, H Li, P Liu, ML Giger, X Zhang - Radiology, 2023 - pubs.rsna.org
Background Breast cancer tumors can be identified as different luminal molecular subtypes
depending on either immunohistochemical (IHC) staining or St Gallen criteria that includes …

MRI of the Lactating Breast

K Xu, M Chung, JH Hayward, T Kelil, AY Lee… - RadioGraphics, 2024 - pubs.rsna.org
The breasts undergo marked physiologic changes during lactation that can make
conventional imaging evaluation with mammography and US challenging. MRI can be a …